These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1833784)

  • 1. Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats.
    O'Neill MF; Dourish CT; Iversen SD
    Psychopharmacology (Berl); 1991; 104(3):343-50. PubMed ID: 1833784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
    Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats.
    Palmatier MI; Bevins RA
    Neuropsychobiology; 2002; 45(2):87-94. PubMed ID: 11893865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
    Dreher JK; Jackson DM
    Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats.
    Mazurski EJ; Beninger RJ
    Psychopharmacology (Berl); 1991; 105(1):107-12. PubMed ID: 1684056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue.
    Furmidge LJ; Exner M; Clark D
    Eur J Pharmacol; 1991 Sep; 202(2):191-9. PubMed ID: 1687032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the dopaminergic system involved in the central effects of nicotine in mice?
    Damaj MI; Martin BR
    Psychopharmacology (Berl); 1993; 111(1):106-8. PubMed ID: 7870924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Neuropharmacology; 2001 Sep; 41(4):454-63. PubMed ID: 11543765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 and D2 dopamine receptors contribute to the locomotor response induced by Group II mGluRs activation in the rat nucleus accumbens.
    Breysse N; Risterucci C; Amalric M
    Pharmacol Biochem Behav; 2002 Sep; 73(2):347-57. PubMed ID: 12117589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant-conditioned locomotion is not affected by blockade of D1 and/or D2 dopamine receptors during conditioning.
    Martin-Iverson MT; McManus DJ
    Brain Res; 1990 Jun; 521(1-2):175-84. PubMed ID: 2145055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor antagonists block nerve growth factor-induced hyperactivity.
    Kobayashi S; Ogren SO; Ebendal T; Olson L
    Eur J Pharmacol; 1997 May; 326(1):1-5. PubMed ID: 9178648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C; Abraini JH; David HN
    Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine receptor antagonists on nicotine-induced attentional enhancement.
    Hahn B; Shoaib M; Stolerman IP
    Behav Pharmacol; 2002 Dec; 13(8):621-32. PubMed ID: 12478212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
    Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.